CDKN2A and breast carcinoma: Since epigenetic repression of CDKN2A has been identified as a key driver of malignant transformation in the breast52, maternal HF intake during pregnancy may increase an offspring’s breast cancer risk by epigenetically silencing this tumor suppressor gene.